XML 52 R41.htm IDEA: XBRL DOCUMENT v3.23.1
Fair Value Measurements - Summary of Fair Value of Financial Assets and Liabilities Measured on Recurring Basis (Details) - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Short-term liabilities:    
Contingent consideration $ 825 $ 1,025
Recurring    
Assets    
Total 56,587 68,670
Short-term liabilities:    
Contingent consideration 825 1,025
Long-term liabilities:    
Contingent consideration 4,089 2,418
Common stock warrant liability 25 32
Total 4,939 3,475
Recurring | Money market funds    
Assets    
Cash equivalents 55,315 66,594
Recurring | Corporate equity securities    
Assets    
Corporate equity securities 1,272 2,076
Fair Value Measured Using - (Level 1) | Recurring    
Assets    
Total 56,587 68,670
Short-term liabilities:    
Contingent consideration 0 0
Long-term liabilities:    
Contingent consideration 0 0
Common stock warrant liability 0 0
Total 0 0
Fair Value Measured Using - (Level 1) | Recurring | Money market funds    
Assets    
Cash equivalents 55,315 66,594
Fair Value Measured Using - (Level 1) | Recurring | Corporate equity securities    
Assets    
Corporate equity securities 1,272 2,076
Fair Value Measured Using - (Level 2) | Recurring    
Assets    
Total 0 0
Short-term liabilities:    
Contingent consideration 0 0
Long-term liabilities:    
Contingent consideration 0 0
Common stock warrant liability 0 0
Total 0 0
Fair Value Measured Using - (Level 2) | Recurring | Money market funds    
Assets    
Cash equivalents 0 0
Fair Value Measured Using - (Level 2) | Recurring | Corporate equity securities    
Assets    
Corporate equity securities 0 0
Fair Value Measured Using - (Level 3) | Recurring    
Assets    
Total 0 0
Short-term liabilities:    
Contingent consideration 825 1,025
Long-term liabilities:    
Contingent consideration 4,089 2,418
Common stock warrant liability 25 32
Total 4,939 3,475
Fair Value Measured Using - (Level 3) | Recurring | Money market funds    
Assets    
Cash equivalents 0 0
Fair Value Measured Using - (Level 3) | Recurring | Corporate equity securities    
Assets    
Corporate equity securities $ 0 $ 0